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MCPIP2 is the least known member of the MCPIP fam-
ily of proteins. Recently we have found that it is a new 
RNase involved in transcript turnover. However, the full 
spectrum of its cellular targets is still unidentified. To 
discover transcripts which are regulated by this protein 
we have employed Sleeping Beauty transposons. This 
tool allows for rapid generation of a stable transgenic 
cell line with inducible expression of the desired gene. In 
this study, we analysed how the Sleeping Beauty system 
itself influences expression of chosen genes, namely IL-
6, Regnase-1 and VEGF. We found that the system alone 
may influence expression of IL-6. Our results indicate 
that Sleeping Beauty transposons should be used with 
caution in studies that are focused on changes in the 
transcript level. 
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INTRODUCTION
Capability to modulate expression of a specific gene 
has been beneficial to understand its function. Since 
discovery of the RNA interference phenomenon in 
1998, double-stranded RNAs (dsRNAs), such as long 
dsRNAs, siRNAs, and microRNAs, have been used as 
research tools to down-regulate an mRNA level by its 
cleavage, degradation or translational repression (the last 
one mainly through miRNA) (Lam et al., 2015). How-
ever,  delivery of exogenous dsRNAs in mammalian cells 
can be associated with unintentional activation of pattern 
recognition receptors of the innate immune system and 
induction of the interferon pathway (Gantier & Williams, 
2007). As an effect, unwanted changes in the level of 
different genes’ induction are observed and can be the 
source of false conclusions. Recently, new tools for ge-
nome editing, such as Zinc Finger Nucleases, TALENs 
(Transcription Activator-Like Effector Nuclease) and 
CRISPR (Clustered Regularly Interspaced Short Palindro-
mic Repeats)-Cas have emerged (Gaj et al., 2013). The 
first two employed complicated protein-DNA interac-
tions for targeting the gene of interest (GOI), while the 
CRISPR-Cas system uses small RNAs with an on-target 
specificity. All three systems generate double-stranded 
DNA breaks which can be repaired through non–homol-
ogousend joining (NHEJ) or homologous recombination 
(HDR). In the course of NHEJ, insertions or deletions 
can be created which in turn may result in frame-shift 
mutations and generation of premature STOP codons. 
HDR-mediated repair is more predictable than NHEJ, 
however, it occurs with lower frequency and additionaly 
a template for recombination has to be delivered into 
the cell (Liu et al., 2019). The biggest threat concerning 
the use of the known tools for genome editing is their 
potential to induce unwanted, off-target effects. This dis-
advantage also applies to RNAi technology.
An opposite approach for studying a gene’s  func-
tion is its overexpression. Two types of vectors are the 
most frequently used for efficient delivery of transgenes, 
non-viral (plasmids) and viral vectors. When plasmids 
are employed as a delivery vehicles, transcription of the 
transgene proceeds with an efficiency depending on the 
type of the promoter present in the plasmid. Viral pro-
moters orchestrate expression of a transgene at a very 
high level which quickly diminishes over several days. 
Use of eukaryotic promoters results in longer and mod-
erate expression of a given transgene. Maintaining pro-
longed selection pressure can lead to integration of the 
expression vector into the genome. However, this is a 
rare event and prone to artifacts (Zucca et al., 2013). 
DNA delivery to mammalian cells can be also propa-
gated by viral vectors derived from retroviruses, adenovi-
ruses, adeno-associated viruses (AAVs), herpesvirus and 
poxvirus. Retroviral vectors can stably integrate into the 
genome of the infected cell but require cell division for 
transduction. Cell division is not needed during infec-
tion with adenoviruses and herpes virus but there is no 
integration into the host genome and the expression of 
the transgene is transient. AAVs also infect many non-
dividing and dividing cell types but have a limited DNA 
capacity (4 kb). Poxvirus vectors have high capacity but 
exert potential cytopathic effects (Kotterman et al., 2015; 
Walther & Stein, 2000). 
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Most of the known plasmid vectors suffer from the 
limited duration of transgene expression. Lack of genom-
ic insertion causes cellular degradation and/or dilution of 
the vector. An additional problem concerns the cellular 
toxicity of the transfection process. This is mainly re-
lated to the high concentration of recombinant proteins 
which results in activation or overloading of specific 
biological pathways or in aggregate creation of recom-
binant proteins (Vavouri et al., 2009). Therefore, despite 
the fact that cell transfection had been carried out since 
the 1990s, the need for better tools for transgene over-
expression is still persisting.
The potential of transposable elements for genome 
modification has been analyzed since the nineties. These 
natural elements have the ability to move within the ge-
nome through a cut-and-paste mechanism. The DNA 
transposons contain a transposase gene flanked by in-
verted terminal repeats (ITRs) which carry the trans-
posase binding sites. Transposase catalyzes excision of 
the transposon from its original location and promotes 
its translocation. Importantly, it is possible to separate 
both functional components of transposons. Any GOI 
flanked by ITRs can undergo transposition in the pres-
ence of a transposase supplied in trans. The synthetic 
Sleeping Beauty transposon is an equivalent to an ancient 
Tc1/mariner-like element present in the salmonid fish 
genome. Given that this element was inactive for 10 mil-
lion years and then reactivated in 1997, it was named 
Sleeping Beauty (SB), after the famous fairy tale. The SB 
has been generated by “reverse engineering” from defec-
tive copies of an ancestral transposon in fish. Its reactiva-
tion included homology comparison in combination with 
site-directed mutagenesis. Additionally, its transpositional 
activity was enhanced by obtaining a hyperactive mutant 
of SB transposase, named SB100x (Kowarz et al., 2015; 
Kebriaei et al., 2017; Hudecek et al., 2017). Advantages 
of the SB system include permanent genomic insertion 
and the ability to maintain and propagate transposon 
vectors as plasmid DNA, meaning simple and inexpen-
sive manufacture. Another advantage of the SB system is 
the target site specificity. Integration of SB transposons 
occurs at sequences containing TA-dinucleotides. There 
are about 30 000 such sequences in the human genome. 
This is an important improvement of SB system over vi-
ral vectors which integrate into the genome at promoters 
and first introns of actively transcribed genes. The SB 
system is also better for gene delivery than viral vectors 
in terms of its lower immunity which is a significant fac-
tor for in vivo studies (Kowarz et al., 2015).
Previously, we have found that MCPIP2 is involved 
in regulation of inflammation through destabilization of 
transcripts of proinflammatory cytokines (Wawro et al., 
2019) To identify new RNA molecules which are regu-
lated by MCPIP2, we employed the SB system for over-
expression of MCPIP2 in a human astrocytoma cell line, 
U251-MG. Surprisingly, we found that the SB system 
alone influences expression of some genes. The aim of 
this work was to analyse the use of  the Sleeping Beauty 
tool for gene expression studies.
MATERIALS AND METHODS
Cell culture. Human astrocytoma U251-MG (ECACC 
09063001), formely known as U373-MG cell line, was 
used in experiments. It was derived from a 75-year old 
male patient with  malignant glioblastoma multiforme 
tumour by an explant technique, and established at the 
Wallenberg laboratory, Uppsala, Sweden (Westermark et 
al., 1973). It was cultured in Dulbecco’s Modified Ea-
gle Medium (DMEM) with 4.5 g/L D-glucose (BioWest, 
Nuaillé) supplemented with 10% (v/v) Fetal Bovine Se-
rum Tetracycline free (BioWest, Nuaillé), at 37°C in a 
humified atmosphere with 5% CO2.
Construct preparation. The pSBtet-GP-MCPIP2 
construct was prepared by cloning ZC3H12B coding 
region (gene encoding MCPIP2, NM_001010888.3) 
into the Sleeping Beauty vector pSBtet-GP (Addgene, 
#60495). PCR products were amplified from a previ-
ously prepared vector pcDNA5/FRT/TO-SF-ZC3H12B, 
containing ZC3H12B coding region fused with Strep-
TagII and FLAG tags using Q5 High Fidelity DNA 
Polymerase (New England Biolabs, Ipswich) (Wawro et 





After gel electrophoresis, PCR products were excised, 
purified (Gel/PCR ME Mini Kit, Syngen, Wroclaw), 
cleaved with the SfiI restriction enzyme (New England 
Biolabs, Ipswich), and purified after enzymatic reaction. 
Then, products were ligated into gel-purified pSBtet-GP 
vector linearized with the SfiI enzyme by using a T4 
DNA ligase (Thermo Fisher Scientific, Waltham). Ob-
tained constructs were verified by restriction analysis and 
sequencing.
Transfection and cell selection. U251-MG cells 
were seeded in 12-well plates at a density of 1x105 cells/
well. 24 hours later, the cells were transfected with 
the pSBtetGP-MCPIP2 vector and the pCMV(CAT)
T7-SB100 vector (Addgene, #34879), using the Tran-
sIT-LT1 Transfection Reagent (Mirus, Madison) accord-
ing to the manufacturers’ instructions. The total amount 
of 1 µg of DNA per well was used in a ratio of 9:1 
(pSBtet-GP: pCMV(CAT)T7-SB100). The next day, the 
cells were transferred to a 6-well plate and puromycine 
(Invivogen, San Diego) was added to a final concentra-
tion of 1 µg/ml. After a week of selection, stable cell 
line was generated. Transfection efficiency was assessed 
by observation of GFP fluorescence under a microscope. 
RNA isolation and cDNA preparation. Total RNA 
was isolated from U251-MG cells modified with the 
Sleeping Beauty system using the Chomczynski method 
(Chomczynski & Sacchi, 2006). The RNA concentra-
tion was measured using NanoDrop ND-1000 spec-
trophotometer (Thermo Fisher Scientific, Waltham). 
1 µg of RNA was treated with RQ1 RNase-free DNase 
(Promega, Madison) according to the manufacturer’s in-
structions, and then reverse-transcribed to cDNA with 
M-MLV-Reverse transcriptase (Promega, Madison) and 
500 ng of oligo(dT)15 primers (Genomed, Warsaw) ac-
cording to the manufacturer’s instructions. 
Real-time PCR. Real-time PCR was performed us-
ing SYBR-A RT HS-PCR Mix (A&A Biotechnology, 
Gdynia) and primers specific to analyzed transcripts (Ge-
nomed, Warsaw):
IL-6: forward: GACAGCCACTCACCTCTTCA  
  reverse: AGTGCCTCTTTGCTGCTTTC 
Regnase-1: forward: GGAAGCAGCCGTGTCCCTATG,  
  reverse: TCCAGGCTGCACTGCTCACTC 
VEGF: forward: ATGCGGATCAAACCTCACCAAGGC   
  reverse: TTAACTCAAGCTGCCTCGCCTTGC 
EF-2: forward: GGTGCAGTGCATCATCGAGGAGTC,   
  reverse: TCGCGGTACGAGACGACCGG
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mRNA level in each sample was analyzed in duplicate, 
and the results were normalized to the reference gene 
(EF-2). The relative level of transcripts was calculated by 
using the ΔΔCT method. 
Western Blot analysis. U251-MG cells with induc-
ible overexpression of MCPIP2  were plated in a 12-well 
plate. The following day, protein expression was induced 
by adding doxycycline to a final concentration of 1 µg/
ml. 24-h after induction, induced cells as well as non-in-
duced control cells were lysed in 100 µl/well of Laem-
mli lysis buffer (0.35 M Tris·HCl, 35% (v/v) glycerol, 
10% (w/v) SDS, 3.6 M β-mercaptoethanol, 0.12 g/ml 
bromophenol blue) and denaturated at 95°C for 7 min-
utes. 20 µl of samples were separated by SDS-PAGE 
and wet transfer was performed onto PVDF membrane 
(Merc Millipore, Burlington). After transfer, the mem-
branes were blocked in 5% (w/v) non-fat dry milk in 
TTBS (20 mM Tris, 150 mM NaCl, 0,1% Tween-20), 
transferred to an antibody solution, and incubated over-
night at 4°C with gentle agitation. The following primary 
antibodies were used: anti-FLAG (D6W5B, 1:2000 Cell 
Signaling, Danvers) or anti-β-actin (13E5, 1:2000 Cell 
Signaling, Danvers). After primary antibody incubation, 
the membranes were washed three times for 5 minutes 
at room temperature with TTBS, and then incubated 
with HRP-conjugated secondary antibodies (anti-rabbit, 
1:10 000, Cell Signalling, Danvers) for 1 hour at room 
temperature with gentle agitation. Then, the membranes 
were washed three times with TTBS (as previously), in-
cubated with Clarity Western ECL Blotting Substrate 
(BioRad, Hercules) for 5 minutes at room temperature, 
and chemiluminescence was detected using Fusion-Fx 
system (VilberLourmat, Marne-la-Vallée). 
Generation of a knockout cell line and analy-
sis of mutations. U251-MG cells were modified using 
CRISPR/Cas9 method targeting the ZC3H12B gene to 
generate a cell line without MCPIP2 expression (U251-
MG-M2-KO). Cas9 mRNA was transcribed in vitro us-
ing the px330 plasmid (Addgene #42230) linearized with 
XbaI (New England Biolabs, Ipswich) as a template, 
according to standard mRNA synthesis protocol (New 
England Biolabs, Ipswich, E2060). Next, cells were 
transfected with synthesized Cas9 mRNA together with 
sgRNA targeting ZC3H12B (CRISPR961504_SGM, 
Thermo Fisher Scientific, Waltham) in 4 hour interval 
using Messenger Max and RNAiMAX (Thermo Fish-
er Scientific, Waltham), respectively, according to the 
manufacturer’s instructions. After transfections, the cells 
were seeded in 96-well plates at a 0.5 cell/well density 
to obtain single cell clones. Presence of a mutation in 
the desired gene was analyzed using the mismatch sen-
sitive nuclease CelI (Qiu et al., 2004). Genomic DNA 
was isolated from the obtained cell clones and wild 
type cells by lysis in Proteinase K lysis buffer (50 mM 
Tris-HCl, pH 8.0, 1 mM EDTA, 0.5% Triton-X sup-
plemented with 1 µg/µl of Proteinase K) and PCR was 
performed using primers flanking the targeted DNA re-
gion. The following primers were used: forward: CCG-
CATGTGCTTTTCAGGAG, reverse: ACCAGGCT-
TACCTCATTGCC.  PCR products were reannealed by 
heating to 95°C and gradual cooling to 4°C. In addition, 
reannealing of each clone with products obtained with 
gDNA from wild type cells was performed. In the next 
step, two reactions were prepared for each tested clone: 
by mixing PCR product itself (4 µl), or by mixing PCR 
product (2 µl) with the product obtained with wild type 
gDNA (2 µl). To each reaction, 6 µl of 1 × CelI buf-
fer was added. Heteroduplexes were cleaved by adding 
0.5 µl/reaction of the mismatch sensitive nuclease CelI 
that recognizes single, unpaired nucleotides and per-
forms cleavage. CelI and CelI buffer were prepared as 
described by Till and others (Till et al., 2006). Products 
of cleavage were separated in 1% agarose gel (w/v) in 
1 × TAE buffer supplemented with 5 µg/ml of ethidium 
bromide and presence of the mutation was analyzed. 
Presence of mutation in selected cloneswas also con-
firmed by sequencing (Genomed, Warsaw).
Statistical analysis and graphs. Statistical analy-
sis and graphs were performed using GraphPad Prism 
(v. 5.0, GraphPad Software Inc.). Scheme of expression 
cassettes was obtained by using Adobe Illustrator CC 
(2019). Detailed information about statistical tests is indi-
cated in figure descriptions. 
RESULTS AND DISCUSSION
Generation of a U251-MG cell line with MCPIP2 
knockout
To maximize the difference between transcriptomes 
from cells with overexpression of MCPIP2 and control 
(reference) cells, we have generated a U251-MG cell line 
with MCPIP2 gene knockout (U251-MG-M2-KO cells) 
by the CRISPR-Cas9 system. We decided to use the all-
RNA approach in which Cas9 and chemically modified 
gRNA are delivered into cells in an RNA form. In com-
parison with unmodified gRNA, synthetic gRNA shows 
improvement in stability and increased efficiency of ge-
nome editing when Cas9 mRNA is co-delivered into 
the cells (Hendel et al., 2015). This approach is also less 
toxic than the classic approach. In cells transfected with 
plasmid DNA the Cas9 protein accumulates over time, 
whereas in Cas9 mRNA transfected cells the protein lev-
el is relatively low with the greatest peak four hours post-
transfection. Because of this features, off-target activity 
for the all-RNA approach is lower than that of plasmid 
DNA transfection (Ranganathan et al., 2015). Using the 
all-RNA approach we were able to obtain a stable cell 
line with ZC3H12B gene editing, confirmed by the CelI 
nuclease assay and sequencing (Fig. 1). After transfection 
with Cas9 mRNA and sgRNA, the cells were seeded into 
a 96-well plate to obtain single cell clones. The clones 
were tested using the CelI mismatch sensitive nuclease 
to discriminate whether a mutation aroused, as well as 
to determinate if one, or both gene copies were altered 
(Fig. 1A). To do that, PCR was performed with DNA 
obtained from mutants as well as with wild type DNA. 
Then, mutant PCR products were reannealed, and addi-
tional reaction was performed at the same time for each 
clone by annealing equal amounts of mutant and wild 
type PCR products. After reannealing, heteroduplexes 
were subjected to CelI cleavage, and products were vi-
sualized by gel electrophoresis. In case of heteroduplex-
es from mutant PCR, if cleavage products are present, a 
mutation occurred only in one allele (heterozygote, +/–). 
However, absence of cleaved products can represent two 
situations: no mutation (wild-type, +/+) or mutation 
present in both alleles (homozygote, –/–). To discrimi-
nate between these two options, additional annealing re-
action with wild-type PCR is necessary. In this situation, 
if cleavage products are present we can assume that the 
mutation occurred in both gene copies (Fig. 1A). In our 
case, we obtained three clones that harbor mutation in 
both alleles (K5, K7, K12, Fig. 1B). Sequencing revealed 
that only in the genome of clone K5 the CRISPR/Cas9 
cleavage caused a deletion of a single nucleotide that 
leads to a frame-shift mutation and generation of a pre-
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mature termination codon (Fig. 1C). Thus, clone K5 was 
used for further experiments and was modified by the 
Sleeping Beauty system.
Generation of a U251-MG cell line with inducible 
overexpression of MCPIP2 protein
MCPIP2 is the least known member of the MCPIP 
protein family which participates in regulation of inflam-
mation through degradation of inflammatory transcripts 
and modification of cell signaling pathways. Our data 
indicate that it possesses an RNase activity, however, 
its molecular targets are largely unknown (Wawro et al., 
2019). Our aim was to identify RNA species regulated 
by MCPIP2. In order to do that, we developed a sta-
ble U251-MG cell line with inducible overexpression of 
MCPIP2 using the SB transposon system. The genetic 
construct was prepared on the basis of the pSBtet-GP 
vector (Fig. 2A). This vector contains an expression cas-
sette encoding MCPIP2 flanked by SB ITRs which al-
lows its integration into the genome in the presence of 
the SB transoposase, and results in generation of a sta-
ble cell line with inducible overexpression of MCPIP2 
(pSBtet-GP-MCPIP2). Expression cassette in pSBtet-
GP contains inducible and constitutive promoters that 
control transcription of different genes. A constitutive 
promoter (RPBSA) drives expression of the reporter 
protein (GFP), the selection marker (puromycin resist-
ance gene) and rtTA protein. The last one in the pres-
ence of doxycycline(Dox) is capable of binding to the 
TRE (tetracycline response element) site that is present 
within the inducible promoter. This binding initializes 
expression of the downstream expression cassette (MC-
PIP2 or luciferase). Integration of the expression cas-
sette into the genome is possible in the presence of a 
transposase, which is encoded by a separate vector called 
Figure 1. Analysis of mutation in the ZC3H12B gene with CelI 
mismatch sensitive nuclease. 
(A) Schematic representation of mutation analysis using the CelI 
mismatch sensitive nuclease. (B) Analysis of mutants with the use 
of CelI nuclease. PCR was performed with gDNA isolated from mu-
tants (K1-K15), as well as wild type U251-MG cells (WT). Mutant 
PCR products and mixtures of mutant and wild type PCR prod-
ucts were reannealed, and cleavage with the CelI nuclease was 
performed. Upper panel: cleavage of mutant PCR products after 
reannealing. Lower panel: cleavage of heteroduplexes of WT PCR 
product and PCR products from the upper panel. K1-K15, analysed 
clones. Arrows on the lower panel indicate products of CelI cleav-
age. “–/–“,” +/–“, “+/+” indicate homozygote, heterozygote or wild 
type genotype, respectively. (C) Alignment of wild type U251-MG 
(WT) and K5, K7, K12 mutant DNA fragments after CRISPR/Cas9 
genome editing targeting ZC3H12B. Image presents fragment of 
the ZC3H12B sequence where mutation occurs. ”–“ indicates de-
leted nucleotides. Black arrow indicates the position of nucleotide 
deleted in K5, leading to a frame-shift.
Figure 2. Generation of U251-MG cell line with the Sleeping 
Beauty transposon-based inducible overexpression of MCPIP2 
protein. 
(A) Backbone of pSBtet-GP and pSBtet-GP-MCPIP2 vectors used 
for generation of the U251-MG-LUC and U251-MG-M2-SB cell 
lines, respectively. ITR, inverted terminal repeats; TRE, inducible 
promoter with tetracycline response element; MCPIP2, coding 
sequence for MCPIP2 with StrepTagII and Flag tags; LUC, coding 
sequence for luciferase. SV40 pA, polyadenylation signal; RPBSA, 
constitutive promoter; GFP, Green Fluorescence Protein reporter 
gene; rtTA, reverse Tetracycline transactivator gene; PURO, puro-
mycine selection gene; bGHpA, polyadenylation signal (Modified 
from Kowarz et al., 2015). (B) Representative images of U251-MG-
M2-KO cells transfected with the pSBtet-GP-MCPIP2 vector 24 
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pCMV(CAT)T7-SB100 (pCMV-SB100X). Both vectors 
have to be co-delivered into the cells during transfection 
in the right proportions. A higher amount of vector en-
coding transposase results in more copies of transgene 
being integrated into the genome. Thanks to the pres-
ence of the selection marker and reporter GFP protein, 
efficiency of transfection can be assessed by simple ob-
servation of GFP fluorescence under a microscope, and 
non-transfected cells can be eliminated by the presence 
of puromycin (Fig. 2B). To avoid different genetic back-
grounds, modified cell line (U251-MG-M2-KO) was 
used for genome editing by the SB transposon system. 
Within a week we were able to obtain a stable cell line 
with inducible overexpression of the MCPIP2 protein 
(U251-MG-M2-SB cell line), which was confirmed by 
real-time PCR and Western Blot analysis (Fig. 3A, B). In 
parallel, we have also generated a stable cell line with in-
ducible overexpression of luciferase, which was obtained 
by transfection of U251-MG-M2-KO cells with the pS-
Btet-GP vector (U251-MG-LUC). 
Sleeping Beauty system itself influences changes in the 
level of transcripts that are known MCPIP2 targets
Using U251-MG-M2-SB cells with inducible overex-
pression of MCPIP2 and U251-MG-M2-KO cells with 
MCPIP2 gene knockout, we decided to examine the 
level of transcripts that are known to be MCPIP2 tar-
gets. We also examined the level of targets which are 
not regulated by this RNase (Wawro et al., 2019). As a 
negative control, we have used the U251-MG-LUC cell 
line with inducible expression of luciferase. Recently, we 
have shown that IL-6 mRNA possessa stem-loop struc-
ture in its 3’UTR which is recognized by MCPIP2 and 
is involved in the interaction between MCPIP2 and this 
transcript, followed by mRNA degradation (Wawro et al., 
2019). Indeed, we observed a decrease in IL-6 mRNA 
level in cells expressing MCPIP2 after induction with 
Dox (Fig. 4A, M2-SB Dox+) in comparison to the con-
trol cells expressing luciferase (Fig. 4A, LUC Dox+). 
A similar pattern of regulation was observed for Re-
gnase-1 mRNA (Fig. 4B, LUC Dox+ and M2-SB Dox+). 
However, the level of transcripts that are not regulated 
by MCPIP2, such as VEGFA mRNA, is also influenced 
by the Dox-induced MCPIP2 overexpression (Fig. 4C, 
LUC Dox+ and M2-SB Dox+). Thus, the system influ-
ences  gene expression in MCPIP2-independent manner. 
Moreover, we have also observed an increase in the level 
of IL-6 mRNA in the control U251-MG-LUC cells, in 
comparison to its level in the U251-MG-M2-KO cells 
(Fig. 4A). This suggests that the system itself influences 
changes in the level of IL-6 mRNA. This phenomenon 
is not reflected by changes in the level of all investigated 
transcripts. The level of Regnase-1 mRNAs is not influ-
enced by SB modification of the U251-MG-M2-KO ge-
nome (Fig. 4B).
The observed stimulation of IL-6 expression caused 
by transposon-mediated  genome modification may be 
explained by specificity of the cell line used in our ex-
periments. Astrocytoma is derived from astrocytes which 
belong to the facultative antigen-presenting cells. Follow-
ing infection of the central nervous system with DNA 
viruses, astrocytes and microglia produce key anti-viral 
and inflammatory mediators, including IL-6 (Van Wag-
Figure 3. Analysis of MCPIP2 expression in the U251-MG-M2-SB 
cell line. 
(A) MCPIP2 mRNA level in U251-MG-M2-SB (M2-SB) and U251-MG-
LUC (LUC) cells. Cells were treated with doxycycline (Dox+) or left 
untreated (Dox-) for 24 hours, and the level of MCPIP2 mRNA was 
measured by real-time PCR. The plot shows mean results from 
three independent experiments (n=3) ± S.D., ***p < 0.001. Two-way 
ANOVA with Bonferroni’s post-hoc test was used. (B) MCPIP2 ex-
pression in U251-MG-M2-SB (M2-SB) cells. Cells were treated with 
doxycycline (Dox+) for 24 hoursor left untreated (Dox-) and MC-
PIP2 protein level was examined by Western Blot analysis with 
anti-FLAG antibody. β-actin was used as a loading control (lower 
panel).
Figure 4. Influence of Sleeping Beauty system and MCPIP2 over-
expression on the level of IL-6, Regnase-1 and VEGFA mRNA.
(A) IL-6 (B) Regnase-1 (C) VEGF mRNA expression profiles in U251-
MG-M2-KO cells (M2-KO), U251-MG-LUC (LUC) or U251-MG-M2-SB 
(M2-SB) with inducible overexpression of MCPIP2 or luciferase. 
Cells were treated with doxycycline (Dox+) for 24 hours or left un-
treated (Dox-) and the levels of the mRNAs of interest were meas-
ured by real-time PCR analysis. The plots show mean results from 
three independent experiments (n=3) ± S.D., *p < 0.05, **p < 0.01, 
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oner & Benveniste, 1999). The DNA sensors such as 
DAI (DNA-dependent activator of interferon-regulatory 
factors) and cGAS (cyclic GMP-AMP synthase) have 
been identified in murine glial cells (Jeffries & Marri-
ott, 2018). Thus, transfection of astrocytes with foreign 
DNA will result in a proinflammatory response. Howev-
er,  edition of the genome by the SB system is stable, the 
transcripts level was analyzed in stable-transfected cells 
after selection of positive/modified cells (puromycin re-
sistance). Therefore explanation of the observed changes 
in IL-6 mRNA level (and lack of changes in Reg-1 and 
VEGFA mRNA level) in the SB-modified control cells 
is debatable. Taken together, our results indicate that the 
Sleeping Beauty approach, although very fast, efficient and 
versatile, may not be the best method for investigating 
changes in the transcriptome since it induces changes in 
the level of some transcripts.
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